Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella

Conditions:   Rubella;   Measles Interventions:   Biological: Measles and Rubella vaccine;   Biological: Measles, Mumps and Rubella vaccine Sponsors:   The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz);   Oswaldo Cruz Institute Not yet recruiting - verified April 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials